A detailed history of State Street Corp transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 690,826 shares of DSGN stock, worth $4.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
690,826
Previous 695,423 0.66%
Holding current value
$4.11 Million
Previous $2.33 Million 59.55%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $5.88 $14,664 - $27,030
-4,597 Reduced 0.66%
690,826 $3.72 Million
Q2 2024

Aug 14, 2024

SELL
$3.23 - $4.77 $11,508 - $16,995
-3,563 Reduced 0.51%
695,423 $2.33 Million
Q1 2024

May 15, 2024

BUY
$2.27 - $4.03 $8,539 - $15,160
3,762 Added 0.54%
698,986 $2.82 Million
Q4 2023

Feb 14, 2024

BUY
$1.99 - $2.76 $4,976 - $6,902
2,501 Added 0.36%
695,224 $1.84 Million
Q3 2023

Nov 14, 2023

BUY
$2.05 - $8.14 $218,710 - $868,440
106,688 Added 18.21%
692,723 $1.63 Million
Q2 2023

Aug 14, 2023

SELL
$4.99 - $7.64 $626,210 - $958,766
-125,493 Reduced 17.64%
586,035 $3.69 Million
Q1 2023

May 15, 2023

SELL
$5.5 - $9.77 $12.8 Million - $22.7 Million
-2,325,932 Reduced 76.57%
711,528 $4.11 Million
Q4 2022

Feb 14, 2023

BUY
$7.86 - $17.2 $16.7 Million - $36.6 Million
2,127,991 Added 233.98%
3,037,460 $31.2 Million
Q3 2022

Nov 15, 2022

BUY
$14.09 - $25.57 $6.48 Million - $11.8 Million
459,688 Added 102.2%
909,469 $15.2 Million
Q2 2022

Aug 15, 2022

BUY
$9.91 - $17.33 $458,238 - $801,339
46,240 Added 11.46%
449,781 $6.3 Million
Q1 2022

May 16, 2022

BUY
$11.17 - $20.89 $684,497 - $1.28 Million
61,280 Added 17.9%
403,541 $6.52 Million
Q4 2021

Feb 14, 2022

BUY
$13.64 - $21.41 $1.78 Million - $2.8 Million
130,653 Added 61.74%
342,261 $7.33 Million
Q3 2021

Nov 15, 2021

BUY
$13.99 - $20.03 $329,030 - $471,085
23,519 Added 12.5%
211,608 $3.11 Million
Q2 2021

Aug 16, 2021

BUY
$19.02 - $29.78 $3.58 Million - $5.6 Million
188,089 New
188,089 $3.74 Million

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $332M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.